Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

48
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
48
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

49
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
49
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

25
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
25
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

36
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
36
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

167
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
167
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

39
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
39

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.

The New England journal of medicine·2026
Same author

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.

Blood cancer journal·2026
Same author

Trends in design of FDA registrational randomized clinical trials in hematology and oncology: a 20-year cohort study.

BMJ connections. Oncology·2026
Same author

Feasibility of decentralized real-world monitoring of SARS-CoV-2 booster vaccines and COVID-19 outcomes in myeloma.

Blood advances·2026
Same author

Ultra High-Resolution Ultrasound Features of Carpal Tunnel Syndrome in Transthyretin Amyloidosis: A Cross-Sectional Study.

Muscle & nerve·2026
Same author

Epigenome-Wide Association Studies of Proteasome Inhibitor-Related Cardiotoxicity in Patients with Multiple Myeloma.

Cancers·2026

相关实验视频

Updated: Sep 18, 2025

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

9.5K

关于偏蛋白性神经病变的最新情况

Rebecca Traub1, Samuel M Rubinstein2, Christopher Dittus2

  • 1University of North Carolina, Chapel Hill, 170 Manning Drive, Chapel Hill, NC, 27599-7025, USA. rtraub@neurology.unc.edu.

Current neurology and neuroscience reports
|June 23, 2025
PubMed
概括

本综述涵盖了关于诊断和管理与单克隆性淋巴病相关的外围神经病变的最新情况. 研究突出了新的治疗点和改善了针对特定疾病的治疗方法,如AL粉样化症和POEMS综合征.

关键词:
抗MAG抗体的神经病变是一种抗MAG抗体的神经病变.单克隆性胃病变是一种单克隆性胃病变.具有神经学意义的单克隆性胃病变.麻性神经病变 麻性神经病变 麻性神经病变这种类型的蛋白质是对蛋白质.

更多相关视频

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

2.9K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K

相关实验视频

Last Updated: Sep 18, 2025

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

9.5K
Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

2.9K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K

科学领域:

  • 神经学 神经学
  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.

背景情况:

  • 周围神经病变是单克隆性骨干病变的常见并发症.
  • 了解副蛋白和神经病变之间的联系对于患者管理至关重要.

研究的目的:

  • 审查最近的临床更新和关于评估和管理与单克隆性骨髓病变相关的外围神经病变的研究.
  • 突出了解致病机制和治疗策略的进展.

主要方法:

  • 最近临床研究和研究的文献综述.
  • 病原机制的分析,包括免疫和补充介导的过程.
  • 评估当前和新兴的治疗策略.

主要成果:

  • 阐明IgM偏蛋白相关神经病变中的致病机制,识别新的治疗点.
  • 改善了AL氨基粉症和POEMS综合征的新化疗方案的治疗结果和降低了神经毒性.
  • 治疗IgM类偏蛋白相关神经病变的治疗药物的进展显示出有前途.

结论:

  • 在神经病变患者中早期识别AL氨基粉症和POEMS综合征至关重要.
  • 临床表型和抗体测试对于评估患有偏蛋白和外围神经病变的患者至关重要.
  • 对致病机制的新见解为向治疗提供了潜在的潜力.